The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.

Breast cancer is the most diagnosed cancer in women. The most commonly diagnosed form of breast cancer in the United States is early-stage breast cancer, for which there are outstanding outcomes.

Lung cancer screening is resulting in a higher incidence of early-stage lung cancer diagnoses. This commonly occurs among older patients with chronic lung disease who are at high risk for complications with attaining pathologic confirmation.

There are many advances in the application of artificial intelligence (AI) in contouring and segmentation, as well as patient specific quality assurance.

There are many ongoing advances in head and neck cancer in the context of radiation therapy delivery, clinical research on treatment options and advanced techniques in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.

This activity reviews the basic concepts of staging, overall treatment paradigm, radiation specific recommendations, radiation simulation, planning and treatment aspects, and literature regarding extremity and retroperitoneal soft tissue sarcomas.

The treatment approaches for lung cancer are rapidly evolving and include integration of new systemic therapies (e.g., immunotherapy and targeted therapies) into combined modality approaches for non-metastatic disease and ablative radiation therapy approaches for oligometastatic disease.

This activity focuses on recent and emerging research in radiation oncology for patients with brain and spine tumors. Special emphasis is placed on radiosurgery dose/fractionation selection, IDH inhibition in glioma and glioma contouring/targeting.